HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas R Lane Selected Research

pyronaridine

10/2022Pyronaridine Protects against SARS-CoV-2 Infection in Mouse.
3/2021Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms.
12/2020Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms.
10/2020Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease.
1/2020Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig.
11/2019Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection.
1/2018The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas R Lane Research Topics

Disease

5Malaria
03/2021 - 01/2018
5Infections
01/2021 - 01/2018
4Ebola Hemorrhagic Fever
10/2020 - 01/2019
2COVID-19
10/2022 - 01/2021
2Human Influenza (Influenza)
03/2021 - 12/2020
2Tuberculosis (Tuberculoses)
01/2019 - 01/2018
1Myasthenia Gravis
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Dementia (Dementias)
01/2021
1Dengue (Dengue Fever)
01/2021
1Nervous System Diseases (Neurological Disorders)
01/2021
1Parkinson Disease (Parkinson's Disease)
01/2021
1Poisoning
01/2021
1Lewy Body Disease (Lewy Body Dementia)
01/2021
1Coronavirus Infections
03/2020
1Chordoma
01/2020
1Chemical and Drug Induced Liver Injury
01/2020
1Opportunistic Infections (Opportunistic Infection)
01/2019

Drug/Important Bio-Agent (IBA)

7pyronaridineIBA
10/2022 - 01/2018
5Pharmaceutical PreparationsIBA
01/2021 - 11/2019
4Quinacrine (Mepacrine)IBA
03/2021 - 01/2019
4Antiviral Agents (Antivirals)IBA
01/2021 - 11/2019
3Tilorone (Tilorone Hydrochloride)IBA
03/2021 - 10/2020
2ArtesunateIBA
10/2020 - 11/2019
1AcetylcholinesteraseIBA
01/2021
1Cholinergic Antagonists (Anticholinergics)IBA
01/2021
1palbociclibIBA
01/2020
1Phosphotransferases (Kinase)IBA
01/2020
1AfatinibIBA
01/2020
1vistusertibIBA
01/2020
1XenobioticsIBA
01/2020
1Drug CombinationsIBA
01/2020
1Antimalarials (Antimalarial Agents)IBA
11/2019
1CytokinesIBA
11/2019
1Immunologic Factors (Immunomodulators)IBA
11/2019
1ChemokinesIBA
11/2019
1Rifampin (Rifampicin)FDA LinkGeneric
01/2018
1DNA-Directed RNA Polymerases (RNA Polymerase)IBA
01/2018

Therapy/Procedure

2Therapeutics
01/2020 - 01/2019